NVS - Mallinckrodt: A Cheap And Attractive Buy Opportunity In March 2019
I had last covered Mallinckrodt (MNK) in August 2018, when the company was trading closer to the $34 levels. I had recommended the company as a buying opportunity, but the market proved me completely wrong.
However, even after failing once, I am daring to recommend this stock in March 2019. Today, Mallinckrodt stands at the brink of a major transformation, as it gets ready to spin off its Specialty Generics and Amitiza businesses in an independent company in the second half of fiscal 2019.
This step is expected to help the